Zoetis Receives a Conditional License from USDA for Canine Atopic
Dermatitis Immunotherapeutic
A conditional license from the USDA was granted to Zoetis in August 2015 for Canine Atopic
Dermatitis Immunotherapeutic *, a new treatment for canine atopic dermatitis.
Canine Atopic
Dermatitis Immunotherapeutic * has been demonstrated to be safe and effective in helping decrease itching within one day and maintains efficacy for one month.